1. Home
  2. MNKD vs GOOS Comparison

MNKD vs GOOS Comparison

Compare MNKD & GOOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNKD
  • GOOS
  • Stock Information
  • Founded
  • MNKD 1991
  • GOOS 1957
  • Country
  • MNKD United States
  • GOOS Canada
  • Employees
  • MNKD N/A
  • GOOS N/A
  • Industry
  • MNKD Biotechnology: Pharmaceutical Preparations
  • GOOS
  • Sector
  • MNKD Health Care
  • GOOS
  • Exchange
  • MNKD Nasdaq
  • GOOS Nasdaq
  • Market Cap
  • MNKD 1.2B
  • GOOS 1.1B
  • IPO Year
  • MNKD 2004
  • GOOS 2017
  • Fundamental
  • Price
  • MNKD $5.54
  • GOOS $13.40
  • Analyst Decision
  • MNKD Buy
  • GOOS Sell
  • Analyst Count
  • MNKD 6
  • GOOS 4
  • Target Price
  • MNKD $10.33
  • GOOS $11.00
  • AVG Volume (30 Days)
  • MNKD 5.3M
  • GOOS 1.7M
  • Earning Date
  • MNKD 08-06-2025
  • GOOS 07-31-2025
  • Dividend Yield
  • MNKD N/A
  • GOOS N/A
  • EPS Growth
  • MNKD 149.32
  • GOOS N/A
  • EPS
  • MNKD 0.11
  • GOOS 0.35
  • Revenue
  • MNKD $301,736,000.00
  • GOOS $1,001,779,346.00
  • Revenue This Year
  • MNKD $14.52
  • GOOS $8.65
  • Revenue Next Year
  • MNKD $12.81
  • GOOS $5.73
  • P/E Ratio
  • MNKD $50.97
  • GOOS $37.84
  • Revenue Growth
  • MNKD 21.48
  • GOOS 2.32
  • 52 Week Low
  • MNKD $3.38
  • GOOS $6.73
  • 52 Week High
  • MNKD $7.63
  • GOOS $15.43
  • Technical
  • Relative Strength Index (RSI)
  • MNKD 72.22
  • GOOS 61.20
  • Support Level
  • MNKD $5.22
  • GOOS $12.82
  • Resistance Level
  • MNKD $6.20
  • GOOS $13.41
  • Average True Range (ATR)
  • MNKD 0.26
  • GOOS 0.53
  • MACD
  • MNKD 0.18
  • GOOS 0.21
  • Stochastic Oscillator
  • MNKD 73.17
  • GOOS 72.66

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

About GOOS Canada Goose Holdings Inc. Subordinate Voting Shares

Canada Goose Holdings Inc is a Canada-based company that designs, manufactures, distributes, and retails premium outerwear for men, women, and children. It operates business through three segments namely, Wholesale and Direct to Consumer (DTC), Other. The DTC segment, which is the key revenue driver, comprises sales through country-specific e-commerce platforms and its company-owned retail stores located in luxury shopping locations. The Wholesale segment comprises sales made to a mix of retailers and international distributors, who are partners that have exclusive rights to an entire market, and travel retail locations. Geographically, it has a presence in Canada, the United States, North America, Greater China, Asia, and Europe, the Middle East, and Africa.

Share on Social Networks: